Your search returned 2 results.

Results
	1.	Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role. [electronic resource] by Rinaldi, Ikhwan Reksodiputro, Ary Harryanto Jusman, Sri Widia Harahap, Alida Setiabudy, Rianto Wanandi, Septelia Inawati Tambunan, Karmel Suharti, Catharina Producer: 20200514 In: Asian Pacific journal of cancer prevention : APJCP vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE). [electronic resource] by Do, Young Rok Kwak, Jae-Yong Kim, Jeong A Kim, Hyeoung Joon Chung, Joo Seop Shin, Ho-Jin Kim, Sung-Hyun Bunworasate, Udomsak Choi, Chul Won Zang, Dae Young Oh, Suk Joong Jootar, Saengsuree Reksodiputro, Ary Harryanto Lee, Won Sik Mun, Yeung-Chul Kong, Jee Hyun Caguioa, Priscilla B Kim, Hawk Park, Jinny Kim, Dong-Wook Producer: 20201204 In: British journal of haematology vol. 189 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search